- Home
- ACXP vs KDLY Comparison
ACXP vs KDLY Comparison
Compare ACXP & KDLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- KDLY
- Stock Information
- Founded
- ACXP 2017
- KDLY 2019
- Country
- ACXP United States
- KDLY United States
- Employees
- ACXP N/A
- KDLY N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- KDLY
- Sector
- ACXP Health Care
- KDLY
- Exchange
- ACXP Nasdaq
- KDLY NYSE
- Market Cap
- ACXP 9.0M
- KDLY 9.5M
- IPO Year
- ACXP 2021
- KDLY 2024
- Fundamental
- Price
- ACXP $0.33
- KDLY $1.52
- Analyst Decision
- ACXP Strong Buy
- KDLY
- Analyst Count
- ACXP 1
- KDLY 0
- Target Price
- ACXP $12.00
- KDLY N/A
- AVG Volume (30 Days)
- ACXP 237.6K
- KDLY 1.7M
- Earning Date
- ACXP 05-13-2025
- KDLY 05-03-2025
- Dividend Yield
- ACXP N/A
- KDLY N/A
- EPS Growth
- ACXP N/A
- KDLY N/A
- EPS
- ACXP N/A
- KDLY N/A
- Revenue
- ACXP N/A
- KDLY $2,719,840.00
- Revenue This Year
- ACXP N/A
- KDLY N/A
- Revenue Next Year
- ACXP N/A
- KDLY N/A
- P/E Ratio
- ACXP N/A
- KDLY N/A
- Revenue Growth
- ACXP N/A
- KDLY N/A
- 52 Week Low
- ACXP $0.32
- KDLY $0.65
- 52 Week High
- ACXP $3.33
- KDLY $5.25
- Technical
- Relative Strength Index (RSI)
- ACXP 24.20
- KDLY N/A
- Support Level
- ACXP $0.32
- KDLY N/A
- Resistance Level
- ACXP $0.45
- KDLY N/A
- Average True Range (ATR)
- ACXP 0.03
- KDLY 0.00
- MACD
- ACXP 0.00
- KDLY 0.00
- Stochastic Oscillator
- ACXP 6.95
- KDLY 0.00
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
About KDLY KINDLY MD INC
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.